Related Experiment Videos
Summary
Diabetic fibrous breast disease (DFBD) presents as benign breast masses in women with long-standing insulin-dependent diabetes mellitus (IDDM). Serial fine-needle aspiration cytology can safely monitor these masses, preventing unnecessary surgeries.
Area of Science:
- Endocrinology
- Oncology
- Radiology
Background:
- Women with long-standing insulin-dependent diabetes mellitus (IDDM) and dense breast tissue may develop benign masses mimicking cancer.
- This condition, termed diabetic fibrous breast disease (DFBD), is often overlooked.
Purpose of the Study:
- To identify and characterize diabetic fibrous breast disease (DFBD).
- To establish diagnostic criteria for DFBD.
- To evaluate the safety of monitoring DFBD with fine-needle aspiration cytology (FNAC).
Main Methods:
- Retrospective review of 36 patients aged 20-54 years with suspected DFBD.
- Detailed analysis of clinical, imaging (ultrasound), and cytological findings.
- Longitudinal monitoring using serial FNAC for masses meeting DFBD criteria.
Main Results:
- 36 patients with DFBD were identified, characterized by IDDM, dense glandular tissue, and specific palpable mass features.
- Diagnostic criteria included hard, irregular, movable, discrete, painless masses with strong ultrasonographic shadowing and FNAC resistance.
- No breast cancer developed in any of the 36 monitored DFBD masses over an average of 6 years.
Conclusions:
- DFBD is a distinct benign breast condition in women with long-standing IDDM.
- Specific clinical and imaging findings, combined with FNAC characteristics, aid in DFBD diagnosis.
- Serial FNAC monitoring is a safe and effective strategy for managing DFBD, avoiding surgical intervention.